By NewsDesk  @infectiousdiseasenews Effective pharmacologic treatments for COVID-19 remains a challenge. The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial showed dexamethasone, a steroid,...

On Tuesday, Vir Biotechnology & GSK announced the COMET-ICE study evaluating VIR-7831, a fully human anti-SARS-CoV-2 monoclonal antibody, will continue into Phase 3 based on an Independent Data Monitoring...

By NewsDesk  @infectiousdiseasenews Case count In an update on the global COVID-19 pandemic, the Russia Ministry of Health has reported that the country’s total confirmed case count has topped...

Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial with approximately 440 patients to evaluate the use of hydroxychloroquine for...

The number of potential therapeutic options for treatment of COVID-19 is growing. Approaches include blocking SARS-CoV-2 from entering cells, disrupting the virus’ replication, antivirals, vaccines,...

The Food and Drug Administration (FDA) says they are committed to doing everything we can to provide timely response efforts to this pandemic and facilitate access to investigational drugs for use in...